Catalyst Pharmaceuticals Inc (CPRX) Stock: A Look at the Analyst Recommendations
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has a higher price-to-earnings ratio of 24.66x compared to its average ratio. CPRX has 36-month beta value of 0.73. Analysts